Chinese Medical Sciences Journal ›› 2012, Vol. 27 ›› Issue (3): 141-146.doi: 10.1016/S1001-9294(14)60046-8
• Original Article • Previous Articles Next Articles
Zhi-jian Sun, Gui-xing Qiu, Xi-sheng Weng, Yu Zhao*, and Jin Jin
Received:
2012-06-12
Revised:
2012-10-08
Published:
2012-10-08
Online:
2012-10-08
About author:
Corresponding author Tel: 86-10-65296081, Fax: 86-10- 65296081, E-mail: zhaoyupumch@hotmail.com
Zhi-jian Sun, Gui-xing Qiu, Xi-sheng Weng, Yu Zhao*, and Jin Jin. Chinese Orthopedic Surgeons’ Practice Regarding Postoperative Thromboembolic Prophylaxis after Major Orthopedic Surgery[J].Chinese Medical Sciences Journal, 2012, 27(3): 141-146.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
Geerts WH, Bergqvist D, Pineo GF, et al.Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition).Chest 2008; 133:381-453. | |
White RH, Keenan CR.Effects of race and ethnicity on the incidence of venous thromboembolism.Thromb Res 2009; 123 Suppl 4:S11-7. | |
Piovella F, Wang CJ, Lu H, et al.Deep-vein thrombosis rates after major orthopedic surgery in Asia.An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.J Thromb Haemost 2005; 3:2664-70. | |
Leizorovicz A.Epidemiology of post-operative venous thromboembolism in Asian patients.Results of the SMART venography study.Haematologica 2007; 92:1194-200. | |
Cohen AT.Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery.Thromb Haemost 2010; 104:919-30. | |
American Academy of Orthopedic Surgeons (US).Guideline on preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty [2011-12-10].http://www.aaos.org/research/guidelines/ VTE/VTE_guideline.asp. | |
Struijk-Mulder MC, Ettema HB, Verheyen CC, et al.Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery.J Thromb Haemost 2010; 8:678- 83. | |
Raskob GE, Hirsh J.Controversies in timing of the first dose of anticoagulant prophylaxis against venous throm- boembolism after major orthopedic surgery.Chest 2003; 124:379-85. | |
Guidelines for prevention of venous thromboembolism after major orthopedic surgery (draft).Chin J Orthop 2007; 27:790-2. | |
Froimson MI, Murray TG, Fazekas AF.Venous thromboembolic disease reduction with a portable pneumatic compression device.J Arthroplasty 2009; 24:310-6. | |
Friedman RJ, Gallus A, Gil-Garay E, et al.Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty—insights from the Multinational Global Orthopaedic Registry (GLORY).Am J Orthop (Belle Mead NJ) 2010; 39:14-21. | |
Salvati EA, Sharrock NE, Westrich G, et al.The 2007 ABJS Nicolas Andry Award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol.Clin Orthop Relat Res 2007; 459:246-54. | |
Dorr LD, Gendelman V, Maheshwari AV, et al.Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.J Bone Joint Surg Am 2007; 89:2648-57. | |
Sugano N, Miki H, Nakamura N, et al.Clinical efficacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population.J Arthroplasty 2009; 24:1254-7. | |
Yokote R, Matsubara M, Hirasawa N, et al.Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population? J Bone Joint Surg Br 2011; 93:251-6. | |
Mavalankar AP, Majmundar D, Rani S.Routine chemoprophylaxis for deep venous thrombosis in Indian patients: Is it really justified? Indian J Orthop 2007; 41:188-93. | |
Strebel N, Prins M, Agnelli G, et al.Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162:1451-6. | |
Hull RD, Pineo GF, Francis C, et al.Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs.warfarin in hip arthroplasty patients: a double-blind, randomized comparison.The North American Fragmin Trial Investigators.Arch Intern Med 2000; 160:2199-207. | |
Hull RD, Pineo GF, Stein PD, et al.Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.Arch Intern Med 2001; 161:1952-60. | |
Eikelboom JW, Quinlan DJ, Douketis JD.Extended-dur- ation prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.Lancet 2001; 358:9-15. | |
Cohen AT, Bailey CS, Alikhan R, et al.Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty—a meta-analysis.Thromb Haemost 2001; 85:940-1. | |
Muntz J.Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues.Am J Surg 2010; 200:413-21. | |
Merli GJ, Malangone E, Lin J, et al.Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database.J Thromb Thrombolysis 2011; 32:89-95. | |
Amin A, Spyropoulos AC, Dobesh P, et al.Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).J Thromb Thrombolysis 2010; 29:326-39. | |
Tribout B, Colin-Mercier F.New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration.Am J Cardiovasc Drugs 2007; 7:1-15. | |
Gordois A, Posnett J, Borris L, et al.The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery.J Thromb Haemost 2003; 1:2167-74. | |
Matzsch T.Thromboprophylaxis with low-molecular-wei- ght heparin: economic considerations.Haemostasis 2000; 30 Suppl 2:141-5; discussion 128-9. | |
Schulman S, Kearon C.Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.J Thromb Haemost 2005; 3: 692-4. | |
Soff GA.A new generation of oral direct anticoagulants.Arterioscler Thromb Vasc Biol 2012; 32:569-74. |
[1] | Quan Jing, Kuo Wan, Lin Ma, Jizhi Zhao. Medical Emergencies in Dental Clinics: A Survey of 2013 Dentists in China [J]. Chinese Medical Sciences Journal, 2020, 35(4): 342-349. |
[2] | Zhou Mengxin, Sun Rui, Chen Yuexin. A Literature Review of Antithrombotic Therapy for Patients of Venous Thromboembolic Events with Comorbidity of Coronary Heart Disease [J]. Chinese Medical Sciences Journal, 2018, 33(2): 120-126. |
[3] | Xu Tao, Zhu Guangjin, Han Shaomei. Study of Zero-Inflated Regression Models in a Large-Scale Population Survey of Sub-Health Status and Its Influencing Factors△ [J]. Chinese Medical Sciences Journal, 2017, 32(4): 218-225. |
[4] | Zhi-jian Sun, Yu Zhao, Giu-xing Qiu, Yi-peng Wang, Xi-sheng Weng, Hong Zhao etc.. Efficacy and Safety of Low Molecular Weight Heparin Prophylaxis for Venous Thromboembolism Following Lumbar Decompression Surgery [J]. Chinese Medical Sciences Journal, 2011, 26(4): 221-226. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|
Supervised by National Health & Family Plan Commission of PRC
9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China
Tel: 86-10-65105897 Fax:86-10-65133074
E-mail: cmsj@cams.cn www.cmsj.cams.cn
Copyright © 2018 Chinese Academy of Medical Sciences
All right reserved.
京公安备110402430088 京ICP备06002729号-1